Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Zoan BioMed Ltd

Zoan BioMed Ltd_logo
23
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Zoan specialise in innovative orthopaedic therapies, using naturally assembled coral as the base bio-material. Bone graft material is the second most transplanted tissue worldwide, and we have developed a safe, effective and natural alternative.

Galway, Ireland, Ireland

Send a message

  • 6

    employees

Anglais

Zoan BioMed Ltd

Anglais

Zoan BioMed Design and develop Bone Grafting material through the sustainable cultivation of marine coral, providing safe and effective solutions for orthopaedic surgeons.  Coral scaffolds are a blueprint of human bone and due to their naturally assembled architecture and integral strength, are ideal bone graft substitutes.    

 

Safety and biocompatibility of Zoan’s devices validated through multiple academic studies. Clinically Voice of the...

See more

Zoan BioMed Design and develop Bone Grafting material through the sustainable cultivation of marine coral, providing safe and effective solutions for orthopaedic surgeons.  Coral scaffolds are a blueprint of human bone and due to their naturally assembled architecture and integral strength, are ideal bone graft substitutes.    

 

Safety and biocompatibility of Zoan’s devices validated through multiple academic studies. Clinically Voice of the Customer by Prof Peter Giannoudis (Leeds General Infirmary) and Prof Robert Flavin (St Vincent’s, Dublin).  Pre-clinical trials at NAMSA confirm homogenous bone formation in long boned animal studies.  

€2.2 million invested/committed to date through EU grants, state funding and private equity.  Launch Product ZOANG03 scheduled for FDA 510(k) submission in Q4 2020.

Highly Innovative pipeline of products spanning  Bone Healing, Antibiotic Delivery & Disease Therapy.  Secured location & manufacturing facility (2,500m2) built out to support 5-year growth plan

  • 1

    Followers

  • 1

    Like

Our latest news

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1250 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1099 Members
Access2EIC – Seal of Excellence
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
1784 Members
BlueInvest
510 Members

Our history

Start in 2015

  • 2015

    Coral scaffolds are a blueprint of human bone, surgeons seeking bone grafts for an ageing population

  • 2015

    Validation studies confirm our coral scaffolds are ideal as bone grafts

  • 2016

    Launched Zoan BioMed to develop safe, natural alternatives to reduce cost and accelerate healing

  • 2018

    Private equity enables our first manufacture site to sustainably produce coral to standard ISO 13485

  • 2020

    Pre-clinical trials confirm the capacity to produce homogeneous bone, safely and effectively

to be continued ...